BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31538142)

  • 21. Analysis of background parenchymal echogenicity on breast ultrasound: Correlation with mammographic breast density and background parenchymal enhancement on magnetic resonance imaging.
    Ko KH; Jung HK; Kim I
    Medicine (Baltimore); 2017 Aug; 96(33):e7850. PubMed ID: 28816987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship Between Breast Ultrasound Background Echotexture and Magnetic Resonance Imaging Background Parenchymal Enhancement and the Effect of Hormonal Status Thereon.
    Kim SJ; Jung HK; Han BK; Lee JH; Oh KS; Lee JS; Lee Y
    Ultrasound Q; 2020 Jun; 36(2):179-191. PubMed ID: 32511210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Background Parenchymal Enhancement on Pre-Operative Breast Magnetic Resonance Imaging: How It Affects Interpretation and the Role of Second-Look Ultrasound in Patient Management.
    Kim SY; Lee HS; Kim EK; Kim MJ; Moon HJ; Yoon JH
    Ultrasound Med Biol; 2016 Dec; 42(12):2766-2774. PubMed ID: 27658753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the kinetic properties of background parenchymal enhancement throughout the phases of the menstrual cycle.
    Amarosa AR; McKellop J; Klautau Leite AP; Moccaldi M; Clendenen TV; Babb JS; Zeleniuch-Jacquotte A; Moy L; Kim S
    Radiology; 2013 Aug; 268(2):356-65. PubMed ID: 23657893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program : A retrospective cohort study.
    Vreemann S; Dalmis MU; Bult P; Karssemeijer N; Broeders MJM; Gubern-Mérida A; Mann RM
    Eur Radiol; 2019 Sep; 29(9):4678-4690. PubMed ID: 30796568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of screening mammography varies by week of menstrual cycle.
    Miglioretti DL; Walker R; Weaver DL; Buist DS; Taplin SH; Carney PA; Rosenberg RD; Dignan MB; Zhang ZT; White E
    Radiology; 2011 Feb; 258(2):372-9. PubMed ID: 21131584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Background parenchymal enhancement: is it just an innocent effect of estrogen on the breast?
    Arslan G; Çelik L; Çubuk R; Çelik L; Atasoy MM
    Diagn Interv Radiol; 2017; 23(6):414-419. PubMed ID: 29097344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Background Parenchymal Enhancement on Cancer Risk Across Different High-Risk Patient Populations Undergoing Screening Breast MRI.
    Sippo DA; Rutledge GM; Burk KS; Mercaldo SF; Dontchos BN; Edmonds CE; Lehman CD
    AJR Am J Roentgenol; 2019 Mar; 212(6):1412-1418. PubMed ID: 30888867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased background parenchymal enhancement of the contralateral breast after two cycles of neoadjuvant chemotherapy is associated with tumor response in HER2-positive breast cancer.
    You C; Gu Y; Peng W; Li J; Shen X; Liu G; Peng W
    Acta Radiol; 2018 Jul; 59(7):806-812. PubMed ID: 29065702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?
    Dontchos BN; Rahbar H; Partridge SC; Korde LA; Lam DL; Scheel JR; Peacock S; Lehman CD
    Radiology; 2015 Aug; 276(2):371-80. PubMed ID: 25965809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI.
    King V; Gu Y; Kaplan JB; Brooks JD; Pike MC; Morris EA
    Eur Radiol; 2012 Dec; 22(12):2641-7. PubMed ID: 22752463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.
    Sogani J; Morris EA; Kaplan JB; D'Alessio D; Goldman D; Moskowitz CS; Jochelson MS
    Radiology; 2017 Jan; 282(1):63-73. PubMed ID: 27379544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Background parenchymal enhancement over exam time in patients with and without breast cancer.
    Melsaether A; Pujara AC; Elias K; Pysarenko K; Gudi A; Dodelzon K; Babb JS; Gao Y; Moy L
    J Magn Reson Imaging; 2017 Jan; 45(1):74-83. PubMed ID: 27285396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between background parenchymal enhancement and tumor response in patients with breast cancer receiving neoadjuvant chemotherapy.
    Rella R; Bufi E; Belli P; Petta F; Serra T; Masiello V; Scrofani AR; Barone R; Orlandi A; Valentini V; Manfredi R
    Diagn Interv Imaging; 2020 Oct; 101(10):649-655. PubMed ID: 32654985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Background parenchymal enhancement and its effect on lesion detectability in ultrafast dynamic contrast-enhanced MRI.
    Honda M; Kataoka M; Iima M; Miyake KK; Ohashi A; Kishimoto AO; Ota R; Nickel MD; Toi M; Togashi K
    Eur J Radiol; 2020 Aug; 129():108984. PubMed ID: 32534350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Machine learning-based prediction of future breast cancer using algorithmically measured background parenchymal enhancement on high-risk screening MRI.
    Saha A; Grimm LJ; Ghate SV; Kim CE; Soo MS; Yoon SC; Mazurowski MA
    J Magn Reson Imaging; 2019 Aug; 50(2):456-464. PubMed ID: 30648316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time to enhancement of breast lesions and normal breast parenchyma in light of menopausal status and menstrual cycle for ultrafast dynamic contrast-enhanced MRI using compressed sensing.
    Yamaguchi K; Nakazono T; Egashira R; Fukui S; Baba K; Hamamoto T; Aishima S; Maruyama K; Nickel D; Irie H
    Magn Reson Imaging; 2023 Feb; 96():102-107. PubMed ID: 36375761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Background parenchymal enhancement in preoperative breast MRI.
    Kohara S; Ishigaki S; Satake H; Kawamura A; Kawai H; Kikumori T; Naganawa S
    Nagoya J Med Sci; 2015 Aug; 77(3):373-82. PubMed ID: 26412883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
    Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
    Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.